|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02361 SINOHEALTH TECH
Nominal 
4.690 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 161,514 | 9.186% | 419,090 | 403,728 | 396,194 | 356,668 |
| Cost of Sales | (71,182) | 8.142% | (170,037) | (170,527) | (172,722) | (197,560) |
| Gross Profit | 90,332 | 10.024% | 249,053 | 233,201 | 223,472 | 159,108 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (6,380) | 527.953% | (8,090) | (12,861) | (24,079) | (2,678) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (2,535) | -- | (467) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 2,018 | -92.284% | 105,528 | 120,148 | 110,741 | 54,474 | |
| Taxation | 1,377 | -- | (11,029) | (8,325) | (9,801) | (261) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (746) | -- | (1,062) | (1,174) | 1,092 | 1,545 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,649 | -89.294% | 93,437 | 110,649 | 102,032 | 55,758 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (7,366) | -36.500% | (22,146) | (25,671) | (26,028) | (6,203) |
| Depreciation & Amortisation | 4,032 | -5.706% | 8,545 | 8,044 | 8,566 | 8,729 |
| Directors' Emoluments | -- | -- | -- | 3,826 | 2,306 | 1,981 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 1.000 | -83.333% | 20.680 | 26.970 | 23.940 | 13.580 |
| DPS (cts) | 0.000 | -- | 6.270 | 19.986 | 6.574 | 3.493 |
| Dividend Payout Ratio (%) | -- | -- | 30.320% | 74.103% | 27.461% | 25.720% |
| Cash flow per share ($) | -- | -- | 0.158 | 0.224 | 0.186 | 0.079 |
| NBV per share ($) | 1.613 | -- | 1.670 | 1.573 | 1.557 | 1.538 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,649 |
| %Change | -89.294% |
| EPS / (LPS) | RMB 0.010 |
| NBV Per Share (¥) | RMB 1.613 |